Papers
2
Total Citations
86
H-Index
2
About
Erhao Bao is a leading figure in urologic oncology, whose research centers on the comparative effectiveness of robotic-assisted surgery versus traditional open approaches for prostate and kidney cancers. His major contributions lie in providing high-quality, evidence-based assessments that guide surgical decision-making. Bao’s landmark 2023 systematic review and meta-analysis of prospective studies comparing robot-assisted and open radical prostatectomy, which has garnered 70 citations, offers critical insights into perioperative outcomes and functional recovery. He further advanced the field with a meta-analysis on robot-assisted partial nephrectomy for highly complex renal masses, demonstrating its safety and efficacy in challenging cases. Through rigorous statistical synthesis, Bao has helped clarify the real-world benefits of minimally invasive techniques, influencing clinical protocols and patient counseling. His work is essential reading for surgeons and researchers seeking to understand the trade-offs between technological innovation and established practice in urologic surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2